PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023
October 30, 2023 at 04:01 pm EDT
Share
The Board of Directors and management of PetMed Express, Inc. have made a decision to suspend the quarterly dividend effective the quarter ended September 30, 2023. This will allow the Company to invest directly in the business with a focus on organic and inorganic growth initiatives. The declaration and payment of future dividends, if any, is discretionary and will be subject to the determination by the Board of Directors.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
PETMED EXPRESS, INC. 
